Navigation Links
Schizophrenia in Medical News

Study Shows a Link Between Schizophrenia & Genetic Mutations

LOS ANGELES, July 20 /PRNewswire/ -- A link between schizophrenia and ultra-rare variants in microRNA genes on the X-chromosome has been identified. Mutations in a subset of these regulatory RNA genes may strongly predispose to schizophrenia. The recently published study in PLoS ONE by ...

International Collaboration led by Dr. Pablo V. Gejman,Researcher At NorthShore University HealthSystem's Research Institute, Finds Genetic Association of Schizophrenia to Chromosome 6p Variant

The July 1, 2009 advance online edition of the journal Nature includes three companion papers describing the results of genome-wide association studies (GWAS) of schizophrenia. Schizophrenia is an elusive and severe psychiatric disorder that affects up to 70 million people worldwide. The causes o...

Possible Gene Regions for Schizophrenia Located

Immune function genes also in the same area, researchers say WEDNESDAY, July 1 (HealthDay News) -- Immune function may play a role in schizophrenia, say scientists who found that schizophrenia patients have genetic variations on a section of chromosome 6 that contains numerous genes as...

Animal model for schizophrenia identifies a novel approach for treating cognitive impairments

Philadelphia, PA, 9 June 2009 - Researchers have been seeking a safe and effective way to treat cognitive impairments associated with schizophrenia by enhancing N-methyl-D-aspartate (NMDA) glutamate receptors. Functional deficits in NMDA receptors may contribute to the underlying neurobiology of ...

Schering-Plough Announces European Filing of SYCREST(R) (asenapine) for the Treatment of Schizophrenia and Bipolar I Disorder

KENILWORTH, N.J., June 2 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today announced that the European Medicines Agency (EMEA) has validated (accepted for review) the company's Marketing Authorization Application (MAA) for SYCREST(R) (asenapine) sublingual tablets for the ...

'Singing brains' offers epilepsy and schizophrenia clues

Studying the way a person's brain 'sings' could improve our understanding of conditions such as epilepsy and schizophrenia and help develop better treatments, scientists at Cardiff University have discovered. Research by a team working in Cardiff University's Brain Research Imaging Centre (CUB...

Hollow mask illusion fails to fool schizophrenia patients

Patients with schizophrenia are able to correctly see through an illusion known as the 'hollow mask' illusion, probably because their brain disconnects 'what the eyes see' from what 'the brain thinks it is seeing', according to a joint UK and German study published in the journal NeuroImage . The...

A Drug That Receives Regulatory Approval for Cognitive Impairment Associated With Schizophrenia Would Earn a Higher Patient Share in the United States Than in Europe

A Therapy's Effect on Executive Function and Functional Capacity are the Attributes that Most Influence Psychiatrists' Prescribing Habits, According to a New Report from Decision Resources WALTHAM, Mass., Feb. 17 /PRNewswire/ -- Decision Resources, one of the world's leading research and advi...

New Research Study in Houston, Texas Seeks Improved Quality of Life for People in the Future with Schizophrenia

Jason Baron, M.D. of Med Labs Research leads research for local patients Houston, TX, February 10, 2009: Imagine going through the day without the ability to concentrate and focus on the things you enjoy and important tasks that you need to complete. Think what it wou...

Johns Hopkins researchers discover new schizophrenia gene

Researchers at the Johns Hopkins University School of Medicine are one gene closer to understanding schizophrenia and related disorders. Reporting in the Jan. 9 issue of the American Journal of Human Genetics , the team describes how a variation in the neuregulin 3 gene influences delusions assoc...

More>>

Schizophrenia in Medical Technology

Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry

- Improvement Was Noted At Day 3 And All Subsequent Study Visits - FORT LEE, N.J., June 3 /PRNewswire/ -- Dainippon Sumitomo Pharma Co., Ltd., (DSP) announced today that positive results from a phase 2 clinical trial for lurasidone in the treatment of patients with schizophrenia have been pu...

Lilly Announces Inconclusive Phase II Study Results for mGlu2/3 at the International Congress on Schizophrenia Research

SAN DIEGO, March 29 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) announced today inconclusive Phase II clinical trial results from Study HBBI investigating LY2140023 monohydrate, also known as mGlu2/3, for the treatment of patients suffering from acute schizophrenia. In Stud...

Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program

SEATTLE, Jan. 28 /PRNewswire/ -- Omeros Corporation today announced that it was awarded $3.1 million in a second tranche of equity and grant funding from The Stanley Medical Research Institute (SMRI) to support late-stage preclinical development of the Company's proprietary product candidates for ...

U.S. FDA Issues Complete Response Letter for SAPHRIS(TM) (ASENAPINE) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder

Schering-Plough expects to respond to agency during first quarter KENILWORTH, N.J., Jan. 14 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for SAPHRIS(TM) (asenapine) s...

FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults

INDIANAPOLIS, Jan. 7 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) announced today that it received a complete response letter from the U.S. Food and Drug Administration (FDA) for olanzapine long-acting injection (LAI) for acute and maintenance treatment of schizophrenia in ad...

Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention

Company's R&D Update Today Unveils Rich Development Pipeline of Compounds Meeting Important Medical Needs KENILWORTH, N.J., Nov. 24 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today revealed top-line results of a long-term Phase III clinical study of its psych...

Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months

BARCELONA, Spain, Sept. 2 /PRNewswire-FirstCall/ -- Final results from a 24-week study presented today at a major medical meeting in Barcelona suggest that investigational olanzapine long-acting injection (LAI) therapeutic doses showed a maintenance of treatment benefit for up to six months. A...

Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference

Efficacy and safety data were generally consistent with oral olanzapine with the exception of injection-related events VENICE, Italy, June 23 /PRNewswire-FirstCall/ -- Results from olanzapine long-acting injection (LAI) clinical trials showed that the efficacy and safety profile of...

Intra-Cellular Therapies Presents Data on Its Schizophrenia and Cognition in Schizophrenia Programs at the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders

NEW YORK, Feb. 15 /PRNewswire/ -- Intra-Cellular Therapies, Inc. (ITI), announced the presentation of preclinical data on ITI-007, its first-in-class dual 5HT2A receptor antagonist/dopamine receptor phosphoprotein modulator (DPPM) for the treatment of schizophrenia, and ITI-002, ITI's family o...

FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment

INDIANAPOLIS, Feb. 6 /PRNewswire-FirstCall/ -- The U.S. Food and Drug Administration's (FDA) Psychopharmacologic Drugs Advisory Committee voted that, with appropriate labeling around excessive sedation events, Zyprexa(R) long-acting injection (olanzapine LAI) has been shown to be effective and...

More>>

Schizophrenia in Medical Definition

Neurobiological Brain Disorder

... purposes and special educational services, others, such as pediatric-onset schizophrenia and bipolar disorder, are not globally accepted as such, resulting in a gre...ngering Psychiatric Symptoms From Hyperthyroidism Protein Biomarkers for schizophrenia Studied in Cerebrospinal Fluid ...

Neuropsychiatry

...o television (Becker, 2004). Another example is schizophrenia , the risk for which may be considerably reduced i..., Gamazo-Garran, Soutullo and Ortuno (2002) schizophrenia Narcissistic/Poor maternal parenting/escapism/ ...chopharmacology, 12, 259-263. Green, M.F. (2001) schizophrenia Revealed: From Neurons to Social Interactions. New...
Schizophrenia in Medical Dictionary

Schizophrenia

Schizophrenia , from the Greek roots skhizein and phrēn, phren- is a psychiatric diagnosis that describes a mental disorder characterized by abnormalities in the perception or expression of reality. Distortions in perception... Disease description, signs and symptoms, treatment, and related ...

Psychosis

...s - Signs and symptoms - Diagnosis methods ... schizophrenia Symptoms and Diagnosis - overview on the diagnosis process for all types of schizophrenia ... schizophrenia and Psychosis - What's the Difference? ... E...

Norepinephrine

...well as the commercial ... : Understanding the scientific basis for psychiatric disorders ... Nonetheless, the impact of norepinephrine in both schizophrenia and depression is significant. ... PubChem Compound Summary ... Norepinephrine is the principal transmitter of most postganglionic sympatheti...

Insulin Shock

...e, and risk ... The Insulin Shock Therapy. Chemical Convulsions and schizophrenia ... schizophrenia treated by insulin shock therapy, 11 % had prompt and total ... Fi...

Hospitalization

...proven value for suicide prevention and can often ... Get detailed information on Hospitalization For Schizophrenia. Covers stabilizing the schizophrenia patient, benefit of hospitalization , milieu therapy. A hospital is an institution for health care, often but not always providing for ... Ho...

Hallucination

...s videos and funny games at Spike.com Hallucination - Definition of Hallucination at Dictionary.com a free online ... Link To hallucination . schizophrenia Symptoms. What Are The Symptoms Of Schizophrenia? ... Your esteem self, woman personality development. First impression and help with ... Halluci...

Etiology

... Schizophrenia: Causes and symptoms Diagnosis Treatment Prognosis Resources schizophrenia ... The etiology of schizophrenia is poorly understood. ... Online Medical Dictionary and glossary with ...

Autistic behavior

... many forms of repetitive or restricted behavior , ... Covers the common signs of autism , its causes and diagnosis, treatment, and more. ... schizophrenia may show some autistic -like behavior , their symptoms usually do ... Behaviors and Interventions Related to Autism Spectrum Disorders ... ...
Schizophrenia in Biological News

LSUHSC research helps link schizophrenia to specific DNA region

New Orleans, LA For the first time, an international group of researchers has found genetic evidence linking schizophrenia to a specific region of DNA on chromosome 6. This is the same area where key genes for immune function are located. The LSUHSC research team was led by Nancy Buccola, APRN,...

Researchers discover link between schizophrenia and diabetes

AUGUSTA, Ga. People with schizophrenia are at increased risk for type 2 diabetes, Medical College of Georgia researchers have found. In a study of 50 people newly-diagnosed with schizophrenia or a related psychotic disorder with no other known risk factors, 16 percent had either diabetes or an...

MU brain imaging center provides research for autism, schizophrenia and Parkinson's disease

Recently, the University of Missouri Department of Psychological Sciences introduced an addition to their field of research with the opening of the Brain Imaging Center (BIC). The BIC will allow MU researchers to conduct behavioral research on diseases that can have tremendous impact, including Pa...

Brain-nourishing molecule may predict schizophrenia relapse

A factor that helps optimize brain formation and function may also provide clues about whether patients suffering with schizophrenia are headed toward relapse, researchers say. Over the next two- and one-half years, they are regularly measuring levels of brain-derived neurotrophic factor, or BD...

Advances in the field of schizophrenia research: New genetic factors identified

Schizophrenia is one of the most serious mental illnesses and is accompanied by symptoms that include delusions and blunted affect. Environmental as well as genetic factors form a complex interplay that leads to the illness. Two papers published in the Internet editions of the professional journal...

Protein marker for schizophrenia risk

A protein found in immune cells may be a reliable marker for schizophrenia risk, report researchers in a new proteomics study appearing in the July issue of Molecular and Cellular proteomics. Schizophrenia is a severe and complex psychiatric illness that affects about 1% of the population. D...

Scientists dig deeper into the genetics of schizophrenia by evaluating microRNAs

NEW YORK Researchers at Columbia University Medical Center have illuminated a window into how abnormalities in microRNAs, a family of molecules that regulate expression of numerous genes, may contribute to the behavioral and neuronal deficits associated with schizophrenia and possibly other brain...

Genetic variant predicts antipsychotic response for schizophrenia patients by ethnicity

Philadelphia, PA, January 8, 2008 Schizophrenia is a developmental disorder with a large genetic component contributing to increased risk. Available antipsychotic medications treat some of the symptoms of schizophrenia, but are typically effective in only a subset of patients. Unfortunately, it...

How schizophrenia develops: Major clues discovered

Schizophrenia may occur, in part, because of a problem in an intermittent on/off switch for a gene involved in making a key chemical messenger in the brain, scientists have found in a study of human brain tissue. The researchers found that the gene is turned on at increasingly high rates during n...

A genetic basis for schizophrenia

Chicago, Illinois, July 21, 2009 Schizophrenia is a severely debilitating psychiatric disease that is thought to have its roots in the development of the nervous system; however, major breakthroughs linking its genetics to diagnosis, prognosis and treatment are still unrealized. Jill Morris, PhD ...

More>>

Schizophrenia in Biological Technology

Schering-Plough Submits Response to FDA for SAPHRIS(TM) (asenapine) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder

Response submitted within one month of FDA complete response letter KENILWORTH, N.J., Feb. 20 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today announced that it has responded to the U.S. Food and Drug Administration (FDA) complete response letter for SAPHRIS(TM) (ase...

Asenapine Meets Primary Endpoint in Long-Term Schizophrenia Relapse Prevention Trial

KENILWORTH, N.J., Oct. 23 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today announced that its novel psychopharmacologic agent asenapine has met the primary endpoint in a long-term schizophrenia relapse prevention trial. Asenapine, which is administered as a fast-dissol...

Galenea and Otsuka Pharmaceutical Extend & Expand Schizophrenia Research Collaboration

CAMBRIDGE, Mass. and TOKYO, Oct. 6 /PRNewswire/ -- Galenea Corp. and Otsuka Pharmaceutical Co., Ltd. announced today the extension and expansion of their research and development collaboration. The two companies have been working together since January 2005 to discover and develop novel therap...

Topline Findings from Comparative Analysis of INVEGA(TM) and Quetiapine in Schizophrenia to be Postered at the 20th Annual U.S. Psychiatric and Mental Health Congress

TITUSVILLE, N.J., Oct. 8 /PRNewswire/ -- Preliminary results from a clinical study comparing INVEGA(TM) (paliperidone) Extended-Release Tablets to quetiapine (marketed as Seroquel(R)) and placebo in patients with recent, acute exacerbation of schizophrenia will be the subject of a poster on di...

FDA Approves RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania

TITUSVILLE, N.J., Aug. 22 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today approved RISPERDAL(R) (risperidone) for the treatment of schizophrenia in adolescents ages 13-17 and for the short-term treatment of bipolar mania associated with manic or mixed episodes of bipolar I di...

SAPHRIS(R) (asenapine) Meets Primary Endpoint in Long-Term Extension Study in Patients With Predominant, Persistent Negative Symptoms of Schizophrenia

KENILWORTH, N.J., July 24 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today announced that its investigational agent SAPHRIS(R) (asenapine) met the primary endpoint over one year of treatment in an extension study in patients with predominant, persisten...

Phase 3 Data Demonstrate Efficacy and Tolerability of Paliperidone Palmitate, an Investigational Long-Acting Therapy for the Treatment of Schizophrenia

Results of Two Trials Identify Potential Initiation Dosing Regimen TITUSVILLE, N.J., Dec. 10 /PRNewswire/ -- Paliperidone palmitate, an investigational long-acting therapy (LAT) demonstrated statistically significant symptom control compared with placebo according to the results of a 13-w...

ChemDiv and Avineuro Extend Collaboration on Alzheimer's Disease and Schizophrenia

SAN DIEGO, Nov. 21 /PRNewswire/ -- ChemDiv Inc. and Avineuro Pharmaceuticals Inc. have extended the term of their research and development collaboration including formulation, safety and early clinical development studies in areas of neurodegenerative and psychiatric disorders. R&D services wi...

Incorrectly cleaved protein leads to schizophrenia

Leuven, Belgium Schizophrenia is a disease that strikes an average of 4000 Belgians every year. The causes of this psychiatric disorder are not yet clear. But now, VIB researchers connected to the Katholieke Universiteit Leuven have discovered that a disturbed cleavage of the Nrg-1 protein lies a...

Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia

MONTVALE, N.J., Dec. 20 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY ) today announced dosing of the first subject in a randomized, double-blind, placebo-controlled Phase 2a clinical trial of MEM 3454, the Company's lead nicotinic alpha-7 receptor partial agonist, in c...
Schizophrenia in Biological Definition

Biological psychology

... cortex to treat their patients. Others may use this knowledge to search for biological causes for common mental illnesses, such as depression and schizophrenia . Many psychologists focus largely on the mental processes of their patients. Biological psychologists work on the basis that there is an organic...

Brain

...ly, only the symptoms of these diseases can be treated, but stem cell research may offer a cure. Mental illnesses , such as clinical depression , schizophrenia , bipolar disorder , and post-traumatic stress disorder , are now recognized as having a biological basis in the brain. These disease can be treate...

Nutrition

...ein in wheat and rye) is suspected of being related to the development of schizophrenia in some cases. (See British Medical Journal, February 21, 2004.) Alz... Obes Rev. 2004 Feb;5(1):13-9. William Eaton et al Coeliac disease and schizophrenia British Medical Journal, February 21, 2004. Janssen I, Katzmarzyk PT, Ro...
Schizophrenia in Biological Dictionary

Structural gene

...hat are expressed as a group and their ... and prevents the read through of RNA polymerase into the three structural genes . ... Patients with schizophrenia carry rare structural gene mutations that impact upon neurodevelopment pathways and may contribute to overall disease phenotype, say US ... Psy...
Other Tags
(Date:12/24/2014)... Today, Yunx.co.uk, a hot style dress supplier that ... occasion outfits, unveils 65 new bridesmaid dresses ... prices, up to 80% off. , Yunx.co.uk’s dresses are ... designs, gorgeous looks and delicate craftsmanship. These new bridesmaid ... to designing and offering high-quality women’s dresses with fast ...
(Date:12/24/2014)... -- The holidays can be a challenge for people who ... and drinks. "This is the season in which many ... Dr. David Dodick, chair of the American Migraine Foundation, said ... to think through food and beverage choices, to help reduce ... professor of neurology at the Mayo Clinic in Scottsdale, Ariz. ...
(Date:12/24/2014)... By Tara Haelle ... (HealthDay News) -- Teens are more likely to start ... of attention-deficit hyperactivity disorder (ADHD) or conduct disorder, ... to counsel families about the risk of substance use ... William Brinkman, research director at Cincinnati Pediatric Research Group, ...
(Date:12/24/2014)... 2014 The Healthy Home Company has a ... families. In-Vest USA is dedicated to supporting ... our first responders. Today, these two organizations have joined forces ... them with body armor through In-Vest’s USA’s Bless the Vest ... happened this past week in New York. , ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 Verde Pointe Dental ... than ever. "Last years homemade Christmas sweater lit up, ... The 2014 winner is Tandy Wilson for the second ... sweater enthusiast," says Kirk Kimmerling DDS. "She took pictures of ... on the sweater." , "Every year I enjoy ...
Breaking Medicine News(10 mins):Health News:Yunx.co.uk Unveils 65 New Bridesmaid Dresses for the UK market 2Health News:Expert Offers Tips for Preventing Holiday Migraines 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 2Health News:ADHD May Raise Teens' Odds for Smoking, Drinking 3Health News:The Healthy Home Company and In-Vest USA Team Up to Save the Lives of Law Enforcement 2Health News:Verde Pointe Dental Associates Announces the 2014 Ugly Sweater Holiday Contest Winner 2
(Date:12/17/2014)... 2014 Research and Markets ( ... "Samsung Galaxy S5 - Home Button Synaptics ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... technology than the iPhone 5S, Samsung introduces for ... product. The Galaxy S5 home button ...
(Date:12/17/2014)... 2014  HITLAB SM announced today its ... to confirm its adherence to current U.S. Food ... HITLAB to conduct regulated smart device and smart ... patient safety and research quality. "HITLAB ... and delivery with innovative technology," said Laura ...
(Date:12/17/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) ... Chemical Sensor Market 2015-2019" report to their ... One major trend upcoming in this ... in biomedical applications. Chemical sensors help in recording ... during surgical procedures. The Global Chemical Sensor market ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
Other Contents